Structural basis of a novel PD-L1 nanobody for immune checkpoint blockade
Zhang, Fei, Wei, Hudie, Wang, Xiaoxiao, Bai, Yu, Wang, Pilin, Wu, Jiawei, Jiang, Xiaoyong, Wang, Yugang, Cai, Haiyan, Xu, Ting, Zhou, Aiwu
Published in Cell discovery (07.03.2017)
Published in Cell discovery (07.03.2017)
Get full text
Journal Article
miR-27-3p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to the Antitumor Agent Olaparib by Targeting PSEN-1, the Catalytic Subunit of Γ-Secretase
Zhao, Meng, Sun, Baisheng, Wang, Yan, Qu, Gengbao, Yang, Hua, Wang, Pilin
Published in Frontiers in oncology (08.06.2021)
Published in Frontiers in oncology (08.06.2021)
Get full text
Journal Article
Monitoring the Response of PD-L1 Expression to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Nonsmall-Cell Lung Cancer Xenografts by Immuno-PET Imaging
Li, Dan, Zou, Sijuan, Cheng, Siyuan, Song, Shuang, Wang, Pilin, Zhu, Xiaohua
Published in Molecular pharmaceutics (05.08.2019)
Published in Molecular pharmaceutics (05.08.2019)
Get full text
Journal Article
Abstract 3022: Using translational tumor growth inhibition modeling approach and population PK analysis to predict efficacious doses for KN026, a HER2 bispecific antibody
Ji, Dongmei, Xiong, Yuan, Yang, Jing, Wang, Pilin, Wang, Jiarong, Yang, Fei, Xu, Junfang
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
JSKN003, A NOVEL BIPARATOPIC ANTI-HER2 ANTIBODY-DRUG CONJUGATE, EXHIBITS POTENT ANTITUMOR EFFICACY
Wang, Pilin, Guo, Kangping, Peng, Jianjian, Sun, Jie, Xu, Ting
Published in Antibody therapeutics (24.07.2023)
Published in Antibody therapeutics (24.07.2023)
Get full text
Journal Article
Structural basis of a novel heterodimeric Fc for bispecific antibody production
Wei, Hudie, Cai, Haiyan, Jin, Yuhao, Wang, Pilin, Zhang, Qingqing, Lin, Yihui, Wang, Weixiao, Cheng, Jinke, Zeng, Naiyan, Xu, Ting, Zhou, Aiwu
Published in Oncotarget (01.08.2017)
Published in Oncotarget (01.08.2017)
Get full text
Journal Article
Abstract PS1-31: Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy
Wang, Xin, Wang, Wenyan, Liu, Jiaxiang, Meng, Xiangzhi, Liu, Jiaqi, Guo, Changyuan, Song, Ying, Cui, Ningyi, Li, Qiao, Xing, Zeyu, Wang, Jie, Zhang, Menglu, Feng, Kexin, Wang, Pilin, Wang, Xiang
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Abstract LB021: KN-052, a novel PDL1/OX40 bispecific antibody, exhibits potent antitumor efficacy
Xu, Ting, Wang, Pilin, Fu, Yang-Xin, Guo, Kangping, Peng, Jianjian
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Get full text
Journal Article
Identification of key genes in HER2-positive breast cancer with brain metastasis via bioinformatics methods
Yang, Ziguo, Sun, Rencheng, Qu, Gengbao, Wang, Feng, Yin, Ziyi, Zhang, Tie, Wang, Pilin, Li, Shaoxiang, Lin, Shuye
Published in Translational cancer research (31.05.2023)
Published in Translational cancer research (31.05.2023)
Get full text
Journal Article
Immuno-PET Imaging of 89 Zr Labeled Anti-PD-L1 Domain Antibody
Li, Dan, Cheng, Siyuan, Zou, Sijuan, Zhu, Dongling, Zhu, Tinghui, Wang, Pilin, Zhu, Xiaohua
Published in Molecular pharmaceutics (02.04.2018)
Published in Molecular pharmaceutics (02.04.2018)
Get full text
Journal Article
Immuno-PET Imaging of 89Zr Labeled Anti-PD-L1 Domain Antibody
Li, Dan, Cheng, Siyuan, Zou, Sijuan, Zhu, Dongling, Zhu, Tinghui, Wang, Pilin, Zhu, Xiaohua
Published in Molecular pharmaceutics (02.04.2018)
Published in Molecular pharmaceutics (02.04.2018)
Get full text
Journal Article
CG001, a C3b-targeted complement inhibitor, blocks 3 complement pathways: development and preclinical evaluation
Li, Ling, Ding, Peipei, Dong, Yanrong, Shen, Shupei, Lv, Xinyue, Yu, Jie, Li, Luying, Chen, Jianfeng, Wang, Pilin, Han, Bing, Xu, Ting, Hu, Weiguo
Published in Blood advances (13.08.2024)
Published in Blood advances (13.08.2024)
Get full text
Journal Article
응고인자 XI(FXI) 결합 단백질
GUO KANGPING, PANG MINJIE, XU TING, WANG LING, WANG PILIN, JIN YUHAO, WANG XIAOXIAO
Year of Publication 10.03.2023
Get full text
Year of Publication 10.03.2023
Patent
Phase I study of KN035, the first subcutaneously administered, novel fusion anti-PD-L1 antibody in patients with advanced solid tumors in China
Xu, Jian-Ming, Qin, Shukui, Zhang, Yun, Zhang, Yaoyue, Jia, Ru, Liu, Rongrui, Zhang, Gairong, Zhao, Chuanhua, Lu, Ni, Liu, Huilong, Xu, Wenlian, Fu, Meng, Cao, Walt, Lu, Haolan, Liu, David, Dong, Ruiping, Wang, Xiaoxiao, Wang, Pilin, Xu, Ting, Gong, John
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
ADAM29 Expression in Human Breast Cancer and its Effects on Breast Cancer Cells In Vitro
Zhao, Meng, Jia, Wang, Jiang, Wen G, Wang, Pilin, DU, Guifang, Cheng, Shan, Song, Maomin
Published in Anticancer research (01.03.2016)
Get full text
Published in Anticancer research (01.03.2016)
Journal Article
A phase I, open, multiple dose, dose escalation and expansion study to evaluate the safety, tolerability, and pharmacokinetics of KN035 (anti-PD-L1 antibody) administered in subcutaneous injection as a single agent to Chinese subjects with advanced solid tumors
Xu, Jianming, Qin, Shukui, Zhang, Yun, Zhang, Yaoyue, Jia, Ru, Liu, Rongrui, Wang, Yan, Zhang, Gairong, Zhao, Chuanhua, Lu, Ni, Ma, Xiaoyu, He, Yue, Yuan, Liwei, Lin, Yihui, Xu, Wenlian, Wang, Xiaoxiao, Wang, Pilin, Xu, Ting, Dong, RuiPing, Gong, John
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article